参考文献：
蒋苏豫，李苏宜.2009.食管癌药物治疗临床研究进展，中国癌症杂志，19（3）：228-233.
李定安，彭开桂.2014.食管癌术前同步放化疗的临床研究进展．中华全科医学，12（9）：1466-1468.
夏铀铀，王磊，宋大安，等.2014.放疗联合雷替曲塞奥沙利铂同步治疗中晚期食管癌的Ⅱ期临床研究，中国肿瘤临床，41（11）：717-719.
中国抗癌协会食管癌专业委员会.2013.食管癌规范化诊治指南，第2版.北京：中国协和医科大学出版社.
Ajani JA，Ilson DH，Kelsen DP.1996.Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.Semin Oncol，23（5 Suppl 12）：55-58.
Akutsu Y，Kono T，Uesato M，et al.2013.S-l monotherapy as second-or third-line chemotherapy for unresectable and recurrentesophageal squamous cell carcinoma.Oncology，84：305-310.
Akutsu Y，Shuto K，Kono T，et al.2012.A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedapla-tin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.Hepatogastroenterology，59：2095-2098.(https://www.daowen.com)
Allum WH，Stenning SP，Bancewicz J，et al.2009.Long-term results of a randomized trial of surgery with or without preoperativechemotherapy in esophageal cancer.J Clin Oncol，27：5062-5067.
Ando N，Iizuka T，Kakegawa T，et al.1997.A randomized trial of surgery with and without chemotherapy for localized squamouscarcinoma of the thoracic esophagus：the Japan Clinical Oncology Group Study.J Thorac Cardiovase Surg，114：205-209.
Ando N，Kato H.Igaki H，et al.2012.A randomized trial comparing postoperative adjuvant chemotherapy with c.isplatin and 5-flu-orouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus（JCOG9907）.Ann Surg Oncol，19：68-74.
Ardalan B，Spector SA，Livingstone AS，et al.2007.Neoadjuvant，surgery and adjuvant chemotherapy without radiation for esopha-geal cancer.Jpn J Clin Oncol，37：590-596.
Armanios M，Xu R，Forastiere AA，et al.2004.Adjuvant chemotherapy for resected adenocarcinoma of the esophagus，gastro-esoph-ageal junction，and cardia：phase II trial（E8296）of the Eastern Cooperative Oncology Group.J Clin Oncol，22：4495-4499.
Assersohn L，Brown G，Cunningham D，et al.2004.Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with pri-mary refractory or relapsed advanced oesophageal and gastric carcinoma.Ann Oncol，15：64-69.